Local Virginia governments add to insulin lawsuits against Eli Lilly, Novo Nordisk, Sanofi, othersnews2023-11-27T19:51:43+00:00November 27th, 2023|Endpoints News|
Shionogi brings generative AI to medical conferences with ‘Warrior’ portrait campaignnews2023-11-27T19:16:00+00:00November 27th, 2023|Endpoints News|
US government turns to more domestic pharma manufacturing to improve supply chain resilience news2023-11-27T19:09:07+00:00November 27th, 2023|Endpoints News|
FDA to SCOTUS: Setting the mifepristone regulations clock back to 2016 is ‘unjustified’news2023-11-27T18:15:59+00:00November 27th, 2023|Endpoints News|
Xenon plans next steps in major depression despite its candidate failing a PhII testnews2023-11-27T16:27:53+00:00November 27th, 2023|Endpoints News|
AstraZeneca’s KRAS deal with Yusen Jianheng; Abeona gets a PDUFA datenews2023-11-27T16:24:24+00:00November 27th, 2023|Endpoints News|
Feng Zhang’s latest gene editing trawl reels in 188 new CRISPR systemsnews2023-11-27T16:24:22+00:00November 27th, 2023|Endpoints News|
Sosei Heptares to take back GPCR agonist after GSK changes coursenews2023-11-27T12:14:16+00:00November 27th, 2023|Endpoints News|
Theseus receives buyout offers from Tang’s Concentra, Foresite, OrbiMednews2023-11-27T12:11:14+00:00November 27th, 2023|Endpoints News|
Aeglea rebrands to Spyre, names new CEO in IBD race against TL1A drugs at Merck, Roche and Sanofinews2023-11-27T12:00:13+00:00November 27th, 2023|Endpoints News|
